Description
TLR5 agonist CBLB502 has been reported playing protective effects again IR, Here we find CBLB502 might protect cis-platin induced liver and kidney damages.
Overall Design
C57BL/6 mice were treated 20mg/kg cis-platin i.p., CBLB502 were pre-treated with 0.2mg/kg at 30min before aminstation of cis-platin, 72 h later, liver and kidney were collected and performed RNA sequencing analysys.
Curator
yq_pan